Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Targeting transcription in heart failure via CDK7/12/13 inhibition

Targeting transcription in heart failure via CDK7/12/13 inhibition

Thumbnail Image
Download
Name

s41467-022-31541-8.pdf

Description
Published version
Size

1.68 MB

Format

Adobe PDF

Checksum (MD5)

62e85e8bf7ef92ab38ecac5b25a7fba4

sword-2023-01-09T16:57:53.original.xml (130 B)
Original SWORD entry document
Author(s)
Hsu, Austin
•
Duan, Qiming
•
Day, Daniel S
•
Luo, Xin
•
McMahon, Sarah
•
Huang, Yu
•
Feldman, Zachary B
•
Jiang, Zhen
•
Zhang, Tinghu
•
Liang, Yanke
more
Date Issued
2022
Journal
Nature Communications
Publisher
Springer Science and Business Media LLC
Citation
Hsu, Austin, Duan, Qiming, Day, Daniel S, Luo, Xin, McMahon, Sarah et al. 2022. "Targeting transcription in heart failure via CDK7/12/13 inhibition." Nature Communications, 13 (1).
Version
Final published version
Abstract
AbstractHeart failure with reduced ejection fraction (HFrEF) is associated with high mortality, highlighting an urgent need for new therapeutic strategies. As stress-activated cardiac signaling cascades converge on the nucleus to drive maladaptive gene programs, interdicting pathological transcription is a conceptually attractive approach for HFrEF therapy. Here, we demonstrate that CDK7/12/13 are critical regulators of transcription activation in the heart that can be pharmacologically inhibited to improve HFrEF. CDK7/12/13 inhibition using the first-in-class inhibitor THZ1 or RNAi blocks stress-induced transcription and pathologic hypertrophy in cultured rodent cardiomyocytes. THZ1 potently attenuates adverse cardiac remodeling and HFrEF pathogenesis in mice and blocks cardinal features of disease in human iPSC-derived cardiomyocytes. THZ1 suppresses Pol II enrichment at stress-transactivated cardiac genes and inhibits a specific pathologic gene program in the failing mouse heart. These data identify CDK7/12/13 as druggable regulators of cardiac gene transactivation during disease-related stress, suggesting that HFrEF features a critical dependency on transcription that can be therapeutically exploited.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution 4.0 International license
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/147016
DOI of Published Version
https://doi.org/10.1038/S41467-022-31541-8
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.